Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:59 PM UTC
| NCT Number | NCT01890590 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 46 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Beth Israel Deaconess Medical Center |
| Last Updated on CT.gov | August 15, 2024 (Aug 15, 2024) |
As of July 13, 2026: Clinical trial NCT01890590 is currently recruiting participants. This clinical trial study for renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Beth Israel Deaconess Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01890590 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01890590 was last updated Aug 15, 2024 (August 15, 2024). HelloStudys verifies this status automatically.